The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study

Case reports indicate that psychiatrists administered ±3,4-methylenedioxymethamphetamine (MDMA) as a catalyst to psychotherapy before recreational use of MDMA as ‘Ecstasy’ resulted in its criminalization in 1985. Over two decades later, this study is the first completed clinical trial evaluating MDM...

Descripción completa

Detalles Bibliográficos
Autores principales: Mithoefer, Michael C, Wagner, Mark T, Mithoefer, Ann T, Jerome, Lisa, Doblin, Rick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2011
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3122379/
https://www.ncbi.nlm.nih.gov/pubmed/20643699
http://dx.doi.org/10.1177/0269881110378371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3122379/
https://www.ncbi.nlm.nih.gov/pubmed/20643699
http://dx.doi.org/10.1177/0269881110378371

Ejemplares similares